[1]冯 颖,苏衍进△,司海龙,等.水陆地黄汤联合盐酸贝那普利对气阴两虚夹瘀型糖尿病肾病氧化应激及临床指标的影响*[J].陕西中医,2020,(5):605-608.[doi:DOI:10.3969/j.issn.10007369.2020.05.014]
　FENG Ying,SU Yanjin,SI Hailong,et al.Effects of Shuilu Dihuang decoction combined with Benazepril hydrochloride on oxidative stress and clinical indicators in type 2 diabetic nephropathy with deficiency of both qi and Yin and blood stasis[J].,2020,(5):605-608.[doi:DOI:10.3969/j.issn.10007369.2020.05.014]
点击复制

水陆地黄汤联合盐酸贝那普利对气阴两虚夹瘀型糖尿病肾病氧化应激及临床指标的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年5期
页码:
605-608
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Effects of Shuilu Dihuang decoction combined with Benazepril hydrochloride on oxidative stress and clinical indicators in type 2 diabetic nephropathy with deficiency of both qi and Yin and blood stasis
作者:
冯 颖; 苏衍进△; 司海龙; 赵倩倩; 王惠玲
陕西中医药大学(咸阳 712046)
Author(s):
FENG Ying; SU Yanjin; SI Hailong; et al.
Shaanxi University of Traditional Chinese Medicine(Xianyang 712046)
关键词:
水陆地黄汤;  盐酸贝那普利;  糖尿病肾病;  气阴两虚;  氧化应激;  临床症状
Keywords:
Shuilu Dihuang decoction;  Benazepril hydrochloride;  Diabetic nephropathy;  Qi and Yin deficiency;  Oxidative stress;  Clinical symptoms
分类号:
R692
DOI:
DOI:10.3969/j.issn.10007369.2020.05.014
文献标志码:
A
摘要:
目的:观察水陆地黄汤对气阴两虚夹瘀型糖尿病肾病氧化应激及临床指标的影响。方法:60例气阴两虚夹瘀型糖尿病肾病患者随机分为对照组与联合组,每组30例,对照组给予盐酸贝那普利片10 mg, 1次/d,联合组在对照组基础上加服水陆地黄汤,1剂/d。治疗12周后观察两组氧化应激指标:谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、丙二醛(MDA)及临床指标:空腹血糖(FPG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c)、尿微量白蛋白(mALB)、24 h尿蛋白定量(24 hU-PQ)、肾小球滤过率(eGFR)的变化及临床症状的改善。结果:联合组治疗总有效率为90.0%,与对照组56.7%比较,差异有统计学意义(P<0.05); 治疗后联合组MDA较治疗前均降低(P<0.05),SOD、GSH-Px均高于治疗前(P<0.05),与对照组比较,差异有统计学意义(P<0.05); 联合组FPG、2 hPG、HbA1c、mALB、24 hU-PQ、eGFR较治疗前均降低(P<0.01)。结论:水陆地黄汤联合盐酸贝那普利可改善气阴两虚夹瘀型糖尿病肾病氧化应激状态,明显缓解临床症状,延缓病程进展。
Abstract:
Objective:To observe the effect of Shuilu Dihuang decoction on oxidative stress and clinical indicators of type 2 diabetic nephropathy with deficiency of both Qi and Yin and blood stasis.Methods:60 patients with DN of deficiency of both Qi and Yin and blood stasis were randomly divided into control group and combined group,30 cases in each group.The control group was given Benazepril hydrochloride tablets 10 mg once a day,The combined group was given Shuilu Dihuang decoction one does per day on the basis of the control group.After 12 weeks of treatment,the changes of oxidative stress indicators:GSH-Px,SOD,MDA,FPG,2 hPG,HbA1c,mALB,24 hU-PQ,eGFR and clinical symptoms were observed.Results:The total effective rate of the combined group was 90.0%,which was different from 56.7% of the control group(P<0.05).After treatment,MDA in the combined group was lower than that before treatment(P<0.05),SOD and GSH-Px were higher than that before treatment(P<0.05),and there were differences between the combined group and the control group(P<0.05).FPG,2 hPG,HbA1c,mALB,24 hU-PQ and eGFR were more effective than those before treatment(P<0.05).Before treatment,they all decreased(P<0.01).Conclusion:Shuilu Dihuang decoction combined with benazepril hydrochloride can improve oxidative stress of type 2 diabetic nephropathy with deficiency of both qi and Yin and blood stasis,relieve clinical symptoms and delay the progress of the disease.

参考文献/References:

[1] 田淋蓥,和 欢,张庚良.糖尿病肾病的中西医治疗概况[J].世界最新医学信息文摘,2019,19(6):70-71.
[2] 田冬琴,刘开翔,谢席胜.糖尿病肾病发病机制、诊断与治疗的研究新进展[J].中国中西医结合肾病杂志,2018,19(10):88-91.
[3] 陈艳凤,张惠娟,杜樱洁.糖尿病肾脏病相关危险因素临床调查[J].世界最新医学信息文摘,2017,17(70):48-50.
[4] 梁文俊.降糖保肾合剂治疗早期糖尿病肾病临床研究[D].北京:北京中医药大学,2004.
[5] 杜 华,柳诗意,石凯峰,等.ACEI/ARB联合中成药治疗早期糖尿病肾病UAER及不良反应的系统评价[J].中国中西医结合肾病杂志,2019,20(5):396-401.
[6] 范 萍.益气活血中药复方通脉口服液干预DN的疗效观察及肾保护作用研究[D].广州:广州中医药大学,2007.
[7] 夏海兄.中西医结合治疗糖尿病肾病临床观察[J].实用中医药杂志,2019,35(6):682-683.
[8] 中华医学会糖尿病分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498.
[9] 中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801.
[10] 周美兰,景 蕊,赵丽娟,等.雷公藤多苷联合缬沙坦治疗糖尿病肾病97例疗效观察[J].陕西医学杂志,2017,46(9):1266-1267.
[11] 郝 阳,郭晓辰,张军平.氧化应激和自噬在动脉粥样硬化中的作用研究新进展[J].中国动脉硬化杂志,2017,25(4):404-410.
[12] 郭福团,许雄伟,潘建峰,等.桑枝多糖对糖尿病肾病小鼠肾皮质氧化应激作用的影响[J].中国药理学通报,2016,32(8):1148-1152.
[13] 路圣垚.Bcl-2抑制剂ABT737通过糖代谢重编程增加氧化应激诱导的卵巢癌细胞凋亡机制的研究[D].长春:吉林大学,2018.
[14] 杨楠楠,刚晓坤,刘 青.糖尿病肾病与氧化应激[J].中国老年学杂志,2013,33(5):1237-1239.
[15] 赵 娟,戴 助.糖尿病肾病药物治疗进展[J].医药导报,2017,36(1):60-64.
[16] 高 鸣,胡江华,孙善红.邵朝弟教授治疗糖尿病肾病的经验[J].四川中医,2006,24(4):6-7.
[17] 王彩丽.从氧化应激角度探讨益气养阴活血方对糖尿病肾病蛋白尿的改善作用[D].北京:北京中医药大学,2013.
[18] 庞 博,董军杰,庞国勋.清热解毒类中药的药理作用及临床应用探讨[J].临床合理用药杂志,2013,6(31):180-181.
[19] 谭 菲,盛瑶环,何 勇.尿毒清颗粒对糖尿病肾病大鼠肾脏抗炎抗氧化保护作用及对TGF-β-1/p38MAPK信号通路影响的研究[J].中药新药与临床药理,2019,30(1):122-127.
[20] 潘险峰,袁仲飞,黄国威,等.丹参川芎嗪注射液联合黄芪注射液对早期糖尿病肾病患者尿UAER、UACR、β2-MG及血清IL-6、IL-18、TNF-α的影响研究[J].陕西中医,2018,39(7):910-912.
[21] 陈 龙.水陆二仙丹加减方治疗早期糖尿病肾病临床观察[J].中国医学创新,2017,14(34):111-113.

备注/Memo

备注/Memo:
*国家自然科学基金资助青年项目(81704066)；陕西省科技厅项目(2011K14-06-06)；陕西省中医药管理局项目(LCMS038)
更新日期/Last Update: 2020-05-14